Subcutaneous Panniculitis-Like T-Cell Lymphoma

Subcutaneous Panniculitis-Like T-Cell Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

10 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4
Recruiting: 1
Ph III recruiting: 0
Growth YoY: —
Industry share: 25%
Top sponsor: City of Hope Medical Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01445535	Phase 1 Trial of Siplizumab and Dose-Adjusted EPOCH-Rituximab in T- and NK-Cell Lymphomas	completed	Phase 1	15	National Cancer Institute (NCI)NIH	1	Nov 3, 2021	clinicaltrials

Data updated 23 days agoSource updated Nov 3, 2021source: clinicaltrials